MAPK3 and thyroid gland carcinoma: Chang indicated that in thyroid cancer, lidocaine caused disruption of the mitochondrial membrane, attenuated ERK1/2 activity, and induced activation of MAPK and c-jun N-terminal kinase, which led to cell apoptosis [24].